Press Releases

WOBURN, Mass., Nov. 29, 2023 /PRNewswire/ -- Spear Bio Inc., a Harvard University biotech spin-off developing scalable solutions for ultrasensitive detection of protein biomarkers announced the completion of a raise of tens of millions of US dollars with its Seed Prime.

Read More

WOBURN, MA. Aug. 17, 2023-- Ultrasensitive immunoassays developer Spear Bio has announced that it has received ISO certification for operating a "Quality Management System which complies with the requirements of ISO 13485: 2016."

Read More

Woburn, MA, July 10, 2023 – Ultrasensitive immunoassays developer Spear Bio is expanding its family of NAB-Sure SARS Cov-2 Neutralizing Antibodies test kits. Previously released kits included the original Wild Type strain and Omicron BA.4/5 variants. It has now added test kits for Omicron variants XBB.1.5 and BQ.1.1.

Read More

WOBURN, Mass., May 15, 2023 /PRNewswire/ — Spear Bio co-founder, President & CTO, Feng Xuan, Ph.D. will be presenting at the upcoming Vaccines Summit (#VSBoston, May 22-24) at the Boston Marriott Newton Hotel. This summit brings together leading biotech and pharma industry experts, academics, and decision-makers for the latest vaccine R&D updates, global perspectives, collaboration, and networking.

Read More

NAB-Sure ™, the new cell-free SARS-CoV-2 neutralizing antibody assay will be featured at Vaccine Summit in Washington D.C. PRESS RELEASE Woburn, MA, October 11 2022 – Feng Xuan, Spear Bio’s Co-Founder and chief technology officer, will share insightful research and results featuring NAB-Sure™ – a new, ultrasensitive immunoassay – during the Vaccine Summit 2022.

Read More